Robinhood Markets, Inc. (HOOD) Competitors & Peers
The 5 largest companies in the same industry as Robinhood Markets, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| MS | Peer | $196.31 | P/E 16.6RSI 42Cap 323.1 B |
| GS | Peer | $935.45 | P/E 14.5RSI 36Cap 272.4 B |
| SCHW | Competitor | $99.03 | P/E 18.0RSI 31Cap 171.3 B |
| IBKR | Peer | $89.24 | P/E 35.4RSI 46Cap 40.4 B |
| CRCL | Peer | $89.00 | P/E 17.8RSI 51Cap 22.6 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- AMZNSupplier
Robinhood operates its entire brokerage infrastructure as a cloud-native platform on Amazon Web Services.
Model-inferred, unverified — treat as a lead, not evidence - SCHWCompetitor
Robinhood + Schwab compete in retail brokerage.
Model-inferred, unverified — treat as a lead, not evidence - ETORCompetitor
eToro competes with Robinhood for retail stock and crypto trading.
Model-inferred, unverified — treat as a lead, not evidence - BULLCompetitor
Competes directly in mobile-first retail stock, options, and cryptocurrency trading brokerage.
Model-inferred, unverified — treat as a lead, not evidence - PLAIDSupplier
Plaid powers Robinhood ACAT linking.
Model-inferred, unverified — treat as a lead, not evidence - VIRTSupplier
Robinhood routes client retail trade orders to Virtu Financial for execution in exchange for Payment for Order Flow (PFOF).
Model-inferred, unverified — treat as a lead, not evidence - FUTUCompetitor
Competes globally in digital commission-free retail trading platforms.
Model-inferred, unverified — treat as a lead, not evidence